Systematic investment
Momentum strategy
Buy the dip strategy
| Revenue per share | N/A |
| Dividend & Yield | N/A¥ (N/A) |
| Beta | N/A |
| Market capitalization | N/A |
| Operating cash flow | N/A |
| ESG Scores | unknown |
These are the result of three automatic investment systems applied to SAWAI PHARMACEUTICAL. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.
Here is the result of two systematic investment strategies applied to SAWAI PHARMACEUTICAL. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.
The following chart shows the equity curve of the two systematic investment strategies applied to SAWAI PHARMACEUTICAL:
The systematic investment strategy that buys the first day of the month would give a performance of -16.38% on the backtest period.
Performance
Latent gain
Invested capital
Annualized return
This is the result of two momentum investment strategies applied to SAWAI PHARMACEUTICAL. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.
The following chart shows all the entries opened by the momentum investment system on SAWAI PHARMACEUTICAL:
Performance
Latent gain
Invested capital
Annualized return
Performance
Latent gain
Invested capital
Annualized return
The following chart shows the equity curve of the two momentum strategies applied to SAWAI PHARMACEUTICAL:
Note: the dividends potentially given by SAWAI PHARMACEUTICAL are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.
The following chart shows the employed capital evolution of the two momentum strategies on SAWAI PHARMACEUTICAL since the beginning:
Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.
The performance achieved by the robo-advisor on SAWAI PHARMACEUTICAL is 4.79%. That represents 225.0$ of latent gain with 4700.0¥ of employed capital. The following chart shows SAWAI PHARMACEUTICAL stock price with all the entries opened by the automated investment system.
Note: The blue line represents the weekly stock price of SAWAI PHARMACEUTICAL, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.
Performance
Latent gain
Invested capital
Annualized return
The following chart shows the result of the investment strategy applied to SAWAI PHARMACEUTICAL:
Note: the dividends potentially given by SAWAI PHARMACEUTICAL are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.
The following chart shows the employed capital evolution since the beginning of the investment strategy on SAWAI PHARMACEUTICAL:
Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.
In this section, I will compare the three previous investment strategies applied to SAWAI PHARMACEUTICAL.
The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:
| Strategy | Latent Profit | CAGR |
|---|---|---|
| Automatic investment | -16.38% | -3.9% |
| Momentum 1 quarter | -17.23% | -4.35% |
| Momentum 2 quarters | -21.95% | -5.9% |
| Non-directional | 4.79% | 2.18% |
Automatic investment
Momentum 1Q
Momentum 2Q
Non-directional
Here are the most positively and negatively correlated stocks with SAWAI PHARMACEUTICAL:
Note: The algorithm computes the probability of correlation between SAWAI PHARMACEUTICAL and the other stocks. There may be false positives or some missing correlated stocks. If the price of SAWAI PHARMACEUTICAL does not vary for 36 weeks, the correlation calculation result will be wrong.
| Company name | SAWAI PHARMACEUTICAL |
| Country | |
| City | |
| Address | |
| Phone | |
| Website | |
| FullTime employees | |
| Industry | |
| Sector | |
| Exchange | XTKS |
| Ticker | 4555.XTKS |
| Market | www.jpx.co.jp |
| Environment ESG Factors | Scores |
|---|---|
| Environment Score | 0 |
| Peer Environment Performance | unknown |
| Environment Percentile | unknown |
| Palm Oil | unknown |
| Nuclear | unknown |
| Fur Leather | unknown |
| GMO | unknown |
| Coal | unknown |
| Pesticides | unknown |
| Animal Testing | unknown |
| Social ESG Factors | Scores |
|---|---|
| Social Score | 0 |
| Peer Social Performance | unknown |
| Social Percentile | unknown |
| Highest Controversy | unknown |
| Peer Highest Controversy Performance | unknown |
| Adult | unknown |
| Gambling | unknown |
| Alcoholic | unknown |
| Tobacco | unknown |
| Catholic | unknown |
| Controversial Weapons | unknown |
| Small Arms | unknown |
| Military Contract | unknown |
| Peer Count | unknown |
Related Controversy:
| Governance ESG Factors | Scores |
|---|---|
| Governance Score | 0 |
| Peer Governance Performance | unknown |
| Governance Percentile | unknown |
| Total ESG Scores: unknown |
| Environment Score: 0 |
| Social Score: 0 |
| Governance Score: 0 |
ESG Performance: unknown
Peer Group: unknown
Peer Esg Score Performance: unknown
Rating Year: unknown
Rating Month: unknown
Max Age: unknown
Percentile: unknown